Lantheus Holdings recently received FDA approval for PYLARIFY TruVu, an enhanced formulation of its PSMA PET imaging agent designed to improve manufacturing efficiency and geographic reach for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results